TrialClinical pharmacology in drug development2025

Phase 1, Single-Center, Double-Blind, Randomized, Placebo-Controlled Studies of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of the Sirtuin 6 Activator SP-624 in Healthy Adults.

Greg Rigdon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.